Related Experiment Video
Updated: Feb 15, 2026
07:32
Murine Flexor Tendon Injury and Repair Surgery
Published on: September 19, 2016
13.7K
Summary
Certain medications like glucocorticoids, fluoroquinolones, and statins can cause tendon injuries, including Achilles tendon rupture. Prompt diagnosis and consideration of drug-induced tendinopathy are crucial for effective management.
Area of Science:
- Pharmacology
- Orthopedics
- Sports Medicine
Background:
- Tendon injuries are increasingly recognized as potential side effects of various medications.
- Historically, glucocorticoids and fluoroquinolones were the primary drug classes associated with tendon issues.
- Recent evidence expands this list to include statins, aromatase inhibitors, and anabolic steroids.
Purpose of the Study:
- To review the clinical presentations, diagnosis, and management of drug-induced tendon injuries.
- To discuss the latest experimental data concerning medication-related tendon pathologies.
- To raise awareness among clinicians about this underreported adverse drug event.
Main Methods:
- Literature review of drug-induced tendon injuries.
- Analysis of clinical case reports and experimental studies.
- Discussion of diagnostic criteria and treatment strategies.
Main Results:
- The Achilles tendon is most commonly affected, but any tendon can be involved.
- Drug-induced tendinopathy and tendon rupture are significant considerations in patients with tendon injuries.
- A broad range of medications, including anabolic steroids, aromatase inhibitors, fluoroquinolones, glucocorticoids, and statins, are implicated.
Conclusions:
- Tendon injury should be strongly suspected in patients with recent use of implicated medications.
- Early recognition and consideration of drug etiology are vital for appropriate patient management.
- Further research into the mechanisms and prevention of drug-induced tendon injuries is warranted.
Related Concept Videos
01:22Burn Injuries
4.6K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.6K
01:30Drug toxicity: Drug–Drug Interaction
22
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
22
01:25Pharmacokinetics: Drug–Drug Interactions
477
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
477
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
167
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167
01:26FDA Approved Drugs: Changes to Approved Drugs
279
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
279
01:13Induced-fit Model
89.7K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.7K